Nordal E, Zak M,
Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne
P, Nielsen S, Straume B, Rygg M; Nordic Study
Group of Pediatric Rheumatology.
Ongoing disease activity and changing
categories in a long-term nordic cohort study of
juvenile idiopathic arthritis.
Arthritis Rheum. 2011 Sep;63(9):2809-18. doi:
10.1002/art.30426.
http://www.ncbi.nlm.nih.gov/pubmed/21560116
Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L,
Aalto K, Malin M, Putto-Laurila A, Honkanen V,
Lahdenne P.
Aggressive combination drug therapy in very
early polyarticular juvenile idiopathic
arthritis (ACUTE-JIA): a multicentre randomised
open-label clinical trial.
Ann Rheum Dis. 2011 Sep;70(9):1605-12.
http://www.ncbi.nlm.nih.gov/pubmed/21623000
Wallace CA, Giannini EH, Huang B, Itert L,
Ruperto N; Childhood Arthritis Rheumatology
Research Alliance; Pediatric Rheumatology
Collaborative Study Group; Paediatric
Rheumatology International Trials Organisation.
American College of Rheumatology provisional
criteria for defining clinical inactive disease
in select categories of juvenile idiopathic
arthritis.
Arthritis Care Res (Hoboken). 2011 Jul;63(7):929-36.
doi: 10.1002/acr.20497.
http://www.ncbi.nlm.nih.gov/pubmed/21717596
Bulatović M, Heijstek MW, Verkaaik M, van
Dijkhuizen EH, Armbrust W, Hoppenreijs EP,
Kamphuis S, Kuis W, Egberts TC, Sinnema G,
Rademaker CM, Wulffraat NM.
High prevalence of methotrexate intolerance
in juvenile idiopathic arthritis: development
and validation of a methotrexate intolerance
severity score.
Arthritis Rheum. 2011 Jul;63(7):2007-13. doi:
10.1002/art.30367.
http://www.ncbi.nlm.nih.gov/pubmed/21437879
Batthish M, Feldman BM, Babyn PS, Tyrrell PN,
Schneider R.
Predictors of hip disease in the systemic
arthritis subtype of juvenile idiopathic
arthritis.
J Rheumatol. 2011 May;38(5):954-8.
http://www.ncbi.nlm.nih.gov/pubmed/21285170
Davì S, Consolaro A, Guseinova D, Pistorio A,
Ruperto N, Martini A, Cron RQ, Ravelli A; MAS
Study Group.
An international consensus survey of
diagnostic criteria for macrophage activation
syndrome in systemic juvenile idiopathic
arthritis.
J Rheumatol. 2011 Apr;38(4):764-8.
http://www.ncbi.nlm.nih.gov/pubmed/21285158
Ravelli A, Varnier GC, Oliveira S, Castell E,
Arguedas O, Magnani A, Pistorio A, Ruperto N,
Magni-Manzoni S, Galasso R, Lattanzi B, Dalprà
S, Battagliese A, Verazza S, Allegra M, Martini
A.
Antinuclear antibody-positive patients should
be grouped as a separate category in the
classification of juvenile idiopathic arthritis.
Arthritis Rheum. 2011 Jan;63(1):267-75. doi:
10.1002/art.30076
http://www.ncbi.nlm.nih.gov/pubmed/20936630
